You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR NIMODIPINE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for nimodipine

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000280 ↗	Glutaminergic Agents for Cocaine Abuse - 5	Completed	National Institute on Drug Abuse (NIDA)	Phase 1	1994-09-01	The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.
NCT00000280 ↗	Glutaminergic Agents for Cocaine Abuse - 5	Completed	VA Connecticut Healthcare System	Phase 1	1994-09-01	The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.
NCT00000280 ↗	Glutaminergic Agents for Cocaine Abuse - 5	Completed	Yale University	Phase 1	1994-09-01	The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.
NCT00000332 ↗	High Dose Nimodipine Treatment Adjunct - 1	Completed	Washington D.C. Veterans Affairs Medical Center	Phase 2	1998-05-01	The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.
NCT00000332 ↗	High Dose Nimodipine Treatment Adjunct - 1	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1998-05-01	The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for nimodipine

Condition Name

Chart
Table

Condition Name for nimodipine
Intervention	Trials
Subarachnoid Hemorrhage, Aneurysmal	6
Aneurysmal Subarachnoid Hemorrhage	5
Subarachnoid Hemorrhage	5
Mild Cognitive Impairment	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for nimodipine
Intervention	Trials
Subarachnoid Hemorrhage	18
Hemorrhage	18
Vasospasm, Intracranial	4
Stroke	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for nimodipine

Trials by Country

Map
Table

Trials by Country for nimodipine
Location	Trials
United States	73
Canada	13
China	9
Czechia	5
Egypt	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for nimodipine
Location	Trials
California	5
Maryland	5
Ohio	4
North Carolina	4
New York	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for nimodipine

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for nimodipine
Clinical Trial Phase	Trials
Phase 4	8
Phase 3	6
Phase 2/Phase 3	4
[disabled in preview]	13
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for nimodipine
Clinical Trial Phase	Trials
Completed	17
Recruiting	8
Terminated	6
[disabled in preview]	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for nimodipine

Sponsor Name

Chart
Table

Sponsor Name for nimodipine
Sponsor	Trials
Edge Therapeutics Inc	3
National Institute on Drug Abuse (NIDA)	2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	2
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for nimodipine
Sponsor	Trials
Other	112
Industry	9
NIH	4
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.